Home » NIR DIAGNOSTICS ANNOUNCES EXCLUSIVE GLOBAL ALLIANCE WITH SHAKLEE CORPORATION
NIR DIAGNOSTICS ANNOUNCES EXCLUSIVE GLOBAL ALLIANCE WITH SHAKLEE CORPORATION
NIR Diagnostics Inc., a leading-edge developer of handheld spectroscopy based medical instruments, announced today that it has entered into a definitive license and royalty agreement with Shaklee Corporation, a nutrition, skin care, and household products company, to develop, manufacture, distribute and market NIR Diagnostics' in-vivo light-based technology and the HemoNIR CO-oximeter device.
CNW Group (http://www.newswire.ca/en/releases/archive/June2006/20/c7652.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct